CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced it has made a minority investment in Q Therapeutics, a biotechnology company pursuing cell therapeutic indications for the central nervous system (CNS). Details of the investment were not disclosed.
